Change From Baseline to Month 3 in Individuals Receiving Immediate Commencement Testosterone Compared With Those Receiving Standard Care
The mean difference and 95% CI refer to the between-group difference over 3 months adjusted for the corresponding measure at baseline. All differences were significant at Testosterone formulations were intramuscular testosterone undecanoate (n = 19) and transdermal testosterone, 1%, gel (n = 12) in the intervention group and intramuscular testosterone undecanoate (n = 18) and transdermal testosterone, 1%, gel (n = 13) in the standard care group. Baseline mean (SD) serum total testosterone concentration was 37.5 (20.2) ng/dL in the intervention group and 25.9 (14.4) ng/dL in the standard care group, and 391.9 (239.2) ng/dL at month 3 in the intervention group.